Laura Adang, MD, PhD
Laura Adang, MD, PhD, MSTR

Laura Adang, MD, PhD

Laura Adang, MD, PhD, MSTR is an attending physician in the Division of Neurology at Children's Hospital of Philadelphia, specializing in the care of children with leukodystrophies.

Areas of expertise: Leukodystrophy


215-590-1719

About Laura Adang

Titles

Attending Physician

Assistant Professor, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Awards and Honors

2022, NINDS Clinical Trials Methodology Course Scholar
2022, Awarded ANA Travel Award
2022, SSIEM Top 10 Abstract Award

Leadership and Memberships

American Academy of Neurology (AAN)
Child Neurology Society (CNS)
Society for the Study of Inborn Errors of Metabolism (SSIEM) 

Education & training

Graduate Degree

PhD in Microbiology - University of Virginia, Charlottesville, VA

Medical Degree

MD - University of Virginia, Charlottesville, VA

Residency

Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

Fellowship

Pediatric Neurology - The Children's Hospital of Philadelphia, Philadelphia, PA

Team affiliations

 View fewer all team affiliations View all all team affiliations

Publications

Publications

2018

Helbig I, Adang L. Teaching NeuroImages: Atrophy in epileptic encephalopathy. Neurology. 2018 Jan 30;90(5):e442-e443.

Pizzino A, Whitehead M, Sabet Rasekh P, Murphy J, Helman G, Bloom M, Evans SH, Murnick JG, Conry J, Taft RJ, Simons C, Vanderver A, Adang LA. Mutations in SZT2 result in early-onset epileptic encephalopathy and leukoencephalopathy. Am J Med Genet A. 2018 Jun;176(6):1443-1448.

Ahrens-Nicklas R, Schlotawa L, Ballabio A, Brunetti-Pierri N, De Castro M, Dierks T, Eichler F, Ficicioglu C, Finglas A, Gaertner J, Kirmse B, Klepper J, Lee M, Olsen A, Parenti G, Vossough A, Vanderver A, Adang LA. Complex care of individuals with multiple sulfatase deficiency: Clinical cases and consensus statement. Mol Genet Metab. 2018 Mar;123(3):337-346. Epub 2018 Jan 31.

2017

Adang LA, Sherbini O, Ball L, Bloom M, Darbari A, Amartino H, DiVito D, Eichler F, Escolar M, Evans SH, Fatemi A, Fraser J, Hollowell L, Jaffe N, Joseph C, Karpinski M, Keller S, Maddock R, Mancilla E, McClary B, Mertz J, Morgart K, Langan T, Leventer R, Parikh S, Pizzino A, Prange E, Renaud DL, Rizzo W, Shapiro J, Suhr D, Suhr T, Tonduti D, Waggoner J, Waldman A, Wolf NI, Zerem A, Bonkowsky JL, Bernard G, van Haren K, Vanderver A; Global Leukodystrophy Initiative (GLIA) Consortium. Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies. Mol Genet Metab. 2017 Sep;122(1-2):18-32. Epub 2017 Aug 20.

2015

Adang L, Berger J. Progressive Multifocal Leukoencephalopathy. F1000Res. 2015 Dec 10;4. pii: F1000 Faculty Rev-1424. eCollection 2015.

2014

Adang LA, Lynch DR, Panzer JA. Pediatric anti-NMDA receptor encephalitis is seasonal. Ann Clin Transl Neurol. 2014 Nov;1(11):921-5. Epub 2014 Oct 30.

2011

Nichols LA, Adang LA, Kedes DH. Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug. PLoS One. 2011 Jan 14;6(1):e14535.

2006

Parsons CH, Adang LA, Overdevest J, O'Connor CM, Taylor JR Jr, Camerini D, Kedes DH. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J Clin Invest. 2006 Jul;116(7):1963-73. Epub 2006 Jun 22.

Adang LA, Parsons CH, Kedes DH. Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection. J Virol. 2006 Oct;80(20):10073-82. 

Patient experience rating

(based on 43 submissions)
  • Clear Explanation
    5 of 5
  • Showed Concern
    4.9 of 5
  • Included in decisions
    5 of 5
  • Would recommend
    5 of 5
  • Discussion of Proposed Treatment
    4.9 of 5
Learn about the patient experience rating system

Comments

  • Dr. Adang was extremely helpful.
    5 of 5
    Jun 16, 2024

  • Dr. Adang and the team were incredible! They were knowledgeable and very detailed. We left feeling more informed and confident.
    5 of 5
    Apr 27, 2024

  • Dr. Adang is absolutely amazing at what she does. Not only is she knowledgeable about my son's condition, she knows how to explain it to my husband and I in ways we can understand. She is kind, patient and so full of compassion. I feel safe in her presence and I feel comforted in knowing that she truly loves my son and will do whatever it takes to make sure he lives as normal of a life that he can.
    5 of 5
    Mar 22, 2024

  • Dr. Adang is wonderful.
    5 of 5
    Oct 27, 2023

  • Dr Adang was absolutely amazing. She is the first doctor that has made us feel like we have a plan going forward & made us feel like she understood the frustrations we were facing. Highly recommended.
    5 of 5
    Jul 28, 2023

  • The best doctor we ever had. Stays overtime, asks us questions, and always listens with care
    5 of 5
    Jun 21, 2023

  • Dr. Adang is incredibly kind and empathetic. She makes sure to sprinkle in positivities when sometimes those can't be seen.
    5 of 5
    Apr 24, 2023

  • The team approach was great and they all took their turns coming in the room as opposed to us having to change rooms- I liked that very much. Each team member was very good and explained their diagnosis and prognosis very well.
    5 of 5
    Apr 11, 2023

  • We love Dr Adang! She is so caring and thoughtful, as well and being an incredibly knowledgeable resource for us.
    5 of 5
    Mar 27, 2023

  • We love Dr. Adang.
    5 of 5
    Mar 09, 2023
View more comments View less comments

About the Patient Experience Rating System

The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient’s protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.